Jonathan Violin - Insider Trading & Ownership

Location
955 Chesterbrook Boulevard, Suite 200, Chesterbrook, PA
Summary
The estimated net worth of Jonathan Violin is at least $10.1M dollars as of June 23, 2025. Jonathan Violin is the Chief Executive Officer, Director of Viridian Therapeutics, Inc.\DE and owns shares of Viridian Therapeutics, Inc.\DE (VRDN) stock worth about $10.1M. Jonathan Violin is the Director of CRESCENT BIOPHARMA, INC. and owns shares of GLYCOMIMETICS INC (GLYC) stock worth about $17.4K.
Signature
/s/ Barbara Bispham, as attorney-in-fact for Jonathan Violin
All Insider Reports
All Insider Reports

Ownership of Jonathan Violin

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
VRDN Viridian Therapeutics, Inc.\DE Chief Executive Officer, Director $10.1M Feb 2, 2023
GLYC GLYCOMIMETICS INC Director $17.4K Jun 23, 2025
ATXS Astria Therapeutics, Inc. Director Jun 11, 2025
DNTH Dianthus Therapeutics, Inc. /DE/ Director May 22, 2025

Insider Transactions Reported by Jonathan Violin:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.